2/11
09:05 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Hill Stephen J.
Neutral
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Hill Stephen J.
2/11
09:04 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lee Gary K.
Neutral
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lee Gary K.
2/11
09:03 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Seely Lynn
Neutral
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Seely Lynn
2/11
09:02 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 10 Filed by: Meltz Mark A
Neutral
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 10 Filed by: Meltz Mark A
2/11
09:01 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 10 Filed by: Bulis Veronica Sanchez
Neutral
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 10 Filed by: Bulis Veronica Sanchez
2/11
08:59 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Feb 10 Filed by: Shook David
Neutral
Report
Form 4 Lyell Immunopharma, Inc. For: Feb 10 Filed by: Shook David
1/6
04:03 pm
lyel
Form 4 Lyell Immunopharma, Inc. For: Dec 24 Filed by: Bulis Veronica Sanchez
Low
Report
Form 4 Lyell Immunopharma, Inc. For: Dec 24 Filed by: Bulis Veronica Sanchez
12/18
04:05 pm
lyel
Form 424B5 Lyell Immunopharma, Inc.
Medium
Report
Form 424B5 Lyell Immunopharma, Inc.
12/16
06:03 am
lyel
Form EFFECT Lyell Immunopharma, Inc.
Low
Report
Form EFFECT Lyell Immunopharma, Inc.
12/8
06:18 am
lyel
Form 8-K Lyell Immunopharma, Inc. For: Dec 07
High
Report
Form 8-K Lyell Immunopharma, Inc. For: Dec 07
12/5
04:37 pm
lyel
Form S-3 Lyell Immunopharma, Inc.
High
Report
Form S-3 Lyell Immunopharma, Inc.
12/5
04:05 pm
lyel
Form 8-K Lyell Immunopharma, Inc. For: Dec 03
High
Report
Form 8-K Lyell Immunopharma, Inc. For: Dec 03
11/14
04:34 pm
lyel
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: ARCH Venture Fund IX, L.P.
Low
Report
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: ARCH Venture Fund IX, L.P.
11/14
04:08 pm
lyel
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: Foresite Capital Fund IV, L.P.
Low
Report
Form SCHEDULE 13G/A Lyell Immunopharma, Inc. Filed by: Foresite Capital Fund IV, L.P.